D.P. Mikhailidis

University College London — United Kingdom

Medicine · Health Sciences

45h-index6.0kcitations289works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Antiplatelet Therapy and Cardiovascular Diseases(39), Lipoproteins and Cardiovascular Health(32), Inflammatory mediators and NSAID effects(26), Urinary Bladder and Prostate Research(23), Eicosanoids and Hypertension Pharmacology(23)

Publications289 total

Oral antiplatelet and anticoagulant drugs in secondary stroke prevention in Polish patients – Results of lipidogram and lipidogen study
Journal of the Neurological Sciences·2019Open Access
P5417Consumption of dairy product and its association with total and cause specific mortality - A population-based cohort study and meta-analysis
European Heart Journal·2018· 2 citedOpen Access
Daylight saving time and myocardial infarction: should we be worried? A review of the evidence.
PubMed·2018· 53 citedOpen Access
Preface
Current Vascular Pharmacology·2017
Letter: statins and cirrhosis
Alimentary Pharmacology & Therapeutics·2017Open Access
3100Effects of morning versus evening statin therapy on lipid profile: a systematic review and meta-analysis
European Heart Journal·2017Open Access
3104Associations between cardiovascular disease, cancer and very low hdl cholesterol in the reasons for geographical and racial differences in stroke (REGARDS) study
European Heart Journal·2017· 2 citedOpen Access
Aggressive treatment of LDL-cholesterol and patients undergoing CABG: news from IMPROVE-IT
Clinical Lipidology·2016Open Access
Karotisstenose - Konservative Therapie bei Karotisstenosen
Gefäßmedizin Scan - Zeitschrift für Angiologie Gefäßchirurgie diagnostische und interventionelle Radiologie·2016
Clinical Lipidology: I shall return
Clinical Lipidology·2016Open Access
Effects of monotherapy with high-dose rosuvastatin compared with the combination of low-dose rosuvastatin with fenofibrate or n-3 fatty acids on non-lipid serum parameters in patients with severe mixed dyslipidemia
2016
Mean Platelet Volume as a Surrogate Marker for Platelet Activation in Patients With Idiopathic Pulmonary Fibrosis
Clinical and Applied Thrombosis/Hemostasis·2015· 51 cited
Emerging Vascular Risk Factors in Women: Any Differences from Men?
Current Medicinal Chemistry·2015· 22 cited
Impact of metabolic syndrome in surgical patients: should we bother?
British Journal of Anaesthesia·2015· 74 cited
Preface
Current Vascular Pharmacology·2015
Investigating dysfunctional-hdl in selected groups of patients at high risk of cardiovascular events (dys-hdl study) - Protocol and organization
Atherosclerosis·2014· 5 cited
Abdominal aortic aneurysm intervention: time to reconsider decision-making criteria?
PubMed·2012· 1 cited
Effect of rosuvastatin monotherapy or in combination with fenofibrate or ω-3 fatty acids on lipoprotein subfraction profile in patients with mixed dyslipidaemia and metabolic syndrome
International Journal of Clinical Practice·2012· 25 cited
Why the United States Center for Medicare and Medicaid Services (CMS) should not extend reimbursement indications for carotid artery angioplasty/stenting (International Angiology 31, 1 (85-89))
2012
Increased plasma visfatin concentration is a marker of an atherogenic metabolic profile
Nutrition Metabolism and Cardiovascular Diseases·2011· 25 cited
page 1 of 15Next →

Frequent Co-authors

Paresh Dandona(12), M.A. Barradas(11), Moses Elisaf(8), Jamie Y. Jeremy(7), C.S. Thompson(7), Robert J. Morgan(6), J.Y. Jeremy(6), Evangelos Liberopoulos(5), Emmanuel S. Ganotakis(5), John A. Papadakis(3), Faiz Mumtaz(3), Vasilios G. Athyros(2), Asterios Karagiannis(2), Christos V. Rizos(2), Gerard Stansby(2), IA Jagroop(2), John Goudevenos(2), J.Y. Jeremy(2), Eleni Bairaktari(2), A.M. Mikhailidis(2)